Skip to content
DraconiticResearch
Search Sources API
216,686 studies31 sourcesUpdated 3 min ago

Oncology

5,539 studies453 in 7 days2,591 in 30 days

Filters
Type
Date
Clear

Latest

5,539 studies

  1. Contextual assessment of perceived health system alignment with National Standards for Cancer Survivorship Care in the American Southeast
    Shirley M. Bluethmann, Stephanie Bunch, Chandylen Nightingale +9
    Journal of Cancer SurvivorshipPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  2. Neuropilin-1 is involved in lytic replication in a subset of primary effusion lymphoma cell lines and for KSHV gene expression in primary endothelial cells
    Anna K. P. Serquina, Julie Lee, Eric Cho +3
    mBioPeer-reviewedCC BYFull textOncologyPMC
  3. Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy
    Michael T. Sandholzer, Clara Serger, Alessia G. Liner +19
    Cell Reports MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Benchmarking of bulk transcriptomic harmonization tools in a multi-platform B-cell lymphoma cohort identifies feature-specific quantile normalization and surrogate variable analysis as top-performing methods
    D. Nikitin, N. M. Borisov, M. Savchenko +9
    bioRxivPreprintCC BYFull text1 citedOncologybioRxiv
  5. Melanoma evolution in the lymph node shapes systemic outcomes
    K. S. Ventre, T. Muijlwijk, R. Stagnitta +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  6. C1q from C1q+ tumor-associated myeloid cells promotes resistance to T-cell engagers and CAR T-cells and is induced by LIF and glucocorticoids
    M. Lopez Vazquez, S. Espinosa Gil, R. Iurlaro +20
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  7. The atypical cadherin CELSR2 regulates distinct epithelial-mesenchymal states and oxidative phosphorylation in triple-negative breast cancer
    J. Koren, N.-I. Y. Saidani, A. El kaoutari +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  8. A Causal Multi-modal AI Model Stratifies Residual Risk and Identifies Candidates for Treatment Escalation in Node-Positive HR+/HER2- Early Breast Cancer
    T. Bachelot, S. Chabaud, J. Lemonnier +11
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  9. Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
    D. Bukovec, M. Gjorgjievska, S. Kocevska +5
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  10. Metabolic profiling of CAR T-cells in patients reveals a shift toward amino acid-supported OXPHOS and informs transporter engineering
    Naomi Taylor, Josquin Moraly, Taisuke Kondo +29
    HALPreprintCC BYFull textOncologyHAL
  11. STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma
    Oliver Kepp, Guido Kroemer
    OncoImmunologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  12. Spatial clustering of esophageal cancer in central Oromia, Ethiopia: A spatial autocorrelation and scan statistics analysis
    Teresa Kisi Beyen, Edom Seife, Biniyam Tefera Deressa +2
    PLOS OnePeer-reviewedCC BY 4.0OncologyPLOS
  13. Patient-specific integration of RNA expression, methylation-derived replication-timing proxies, and histomorphology for pancreatic cancer subtyping
    Alejandro Leyva, M. Khalid Khan Niazi
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  14. Bacterial RNA downregulates MHC-I in tumor cell lines, promoting NK response and delaying tumor growth
    Agustina Serafino, Mónica Vermeulen, Yasmín A. Bertinat +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  15. Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer
    Chishun Zhou, Qing Ning, Xin Jin +8
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyPLOS
  16. Choroid plexus volume variation in patients with gliomas, glioneuronal and neuronal tumors: Associations with tumor characteristics
    Jia Sun, Minghao Wu, Junjie Li +8
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPhysiologyPLOS
  17. R-package agentBayes: Likelihood-based statistical methods for agent-based models
    Niklas Moser, Dmitri Finkelshtein, Georgy Chargaziya +5
    PLOS Computational BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  18. Epstein-Barr virus-encoded microRNA-BART17-5p suppresses cell proliferation and metastasis by targeting CERK
    Peilin Wu, Xiazhen Xu, Qiong Wu +5
    PLOS PathogensPeer-reviewedCC BY 4.0Full textOncologyPLOS
  19. Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer
    Benoit Paquette, Hélène Therriault, Isabelle Gauthier +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  20. PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma
    Yekai Feng, Yonghang Zhang, Haibo Ou +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  21. Anticancer activity of asiatic acid in cisplatin-resistant human neuroblastoma SH-SY5Y and its unaffected effect on human neural stem cells
    Apisada Jiso, Laphatrada Yurasakpong, Amarin Thongsuk +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  22. Prognostic value of melatonin-related signature genes in lung adenocarcinoma
    Hongxia Guo, Lixia Liu, Ying Lu +3
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  23. Does acute inflammation triggered by infection promote cancer progression?
    Felipe Valença-Pereira, Bryan Johnson, James DeGregori +1
    PLOS BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  24. Enhancing early-stage breakthrough technology identification: A CatBoost model optimized with the SABO algorithm
    Ming Lei, Yin Yu
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  25. Modelling the impact of physical activity on MASLD in Saudi Arabia
    Carolyn Wallace, Saleh A. Alessy, Faisal Abaalkhail +20
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPhysiologyPLOS